Spero Therapeutics (NASDAQ:SPRO) Raised to “Strong-Buy” at Wall Street Zen
Spero Therapeutics (NASDAQ:SPRO – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “hold” rating to a “strong-buy” rating in a research report issued on Sunday. Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Spero Therapeutics in a research report on Thursday, January 22nd. One analyst has […]
31 Mar 01:34 · The Cerbat Gem